Exposure to ionizing radiation and other DNA-damaging carcinogens is strongly associated with induction of malignancies. Prevailing paradigms attribute this association to the induction of oncogenic mutations, as the incidence of oncogenic events is thought to limit initiation and progression of cancers. On the other hand, random mutagenic and genotoxic effects of irradiation are likely to alter progenitor cell populations and the microenvironment, thus altering the selective effects of oncogenic mutations. Using competitive bone marrow transplantation experiments in mice, we show that ionizing irradiation leads to a persistent decline in the numbers and fitness of hematopoietic stem cells, in part resulting from persistent induction of reactive oxygen species. Previous irradiation dramatically alters the selective effects of some oncogenic mutations, substantially inhibiting clonal expansion and leukemogenesis driven by Bcr-Abl or activated N-Ras oncogenes but enhancing the selection for and leukemogenesis driven by the activated Notch1 mutant ICN. Irradiation-dependent selection for ICN expression occurs in a hematopoietic stem cell-enriched pool, which should facilitate the accumulation of additional oncogenic events at a committed T-progenitor stage critical for formation of T-lymphocytic leukemia stem cells. Enhancement of ICNdriven selection and leukemogenesis by previous irradiation is in part non-cell autonomous, as partial restoration of normal hematopoiesis can reverse these effects of irradiation. These studies show that irradiation substantially alters the adaptive landscape in hematopoietic progenitors and suggest that the causal link between irradiation and carcinogenesis might involve increased selection for particular oncogenic mutations. [Cancer Res 2009;69(18):7262-9] 
Introduction
Exposure to ionizing radiation is strongly associated with the induction of malignancies in humans and in animal models (1, 2) . Because ionizing irradiation is a potent mutagen, and cancer development requires the acquisition of mutations in oncogenes and tumor suppressors, prevailing paradigms attribute cancer causation by DNA damaging carcinogens to the direct induction of oncogenic events by these agents (3, 4) .
From an evolutionary perspective, to be able to trigger clonal expansion, an initiating oncogenic event will typically need to provide a mutated cell with a gain in fitness relative to other cells competing for the same niches. Therefore, the ability or inability of oncogenic mutations to cause clonal expansion should be dependent on the fitness of cells competing for niches with limited resources and on the state of the microenvironment (5, 6) . Whereas mutagenic actions of carcinogens, including g-irradiation, might increase the frequency of oncogenic events, induction of mutations that reduce cellular fitness is a much more probable outcome of random mutations (7) . In addition to the direct induction of mutations that reduce cellular fitness, DNA damage results in altered nuclear architecture, which may also contribute to decreased cellular fitness (8) . Moreover, irradiation has been shown to cause dramatic alterations in the cellular microenvironment (9) , and alterations in the microenvironment are expected to significantly affect cellular fitness as well.
Several groups have proposed that growth-inhibitory conditions can select for oncogenic mutations that provide resistance to the inhibitory context (10) (11) (12) (13) (14) (15) . More specifically, we have previously hypothesized that reductions of fitness caused by accumulated DNA damage should lead to selection for adaptive oncogenic mutations (6) . Using the mouse hematopoietic system, we explored the effects of g-irradiation on the fitness of progenitor cells as well as the effects of prior irradiation on the selective effects conferred by different oncogenic mutations. Our results suggest that the causal link between irradiation and cancer involves changes in the adaptive landscape, which increase selection for particular oncogenic events.
Materials and Methods

Retroviral constructs and infections. MSCV-ires-GFP (MiG)-ICN (16),
MiG-N-Ras12D, MiG-Akt (17) , and MiG-p185-Bcr-Abl (18) were the generous gifts of Drs. Warren Pear (University of Pennsylvania, Philadelphia, PA), Yosef Refaeli (University of Colorado Denver, Aurora, CO), and Zonghan Dai (Texas Tech, Amarillo, TX), respectively. MiG-Myc was generated by cloning human c-myc cDNA into MiG. Viral particles were assembled using cNXEco packaging cells as previously described (10) . Freshly isolated bone marrow (BM) cells were transduced with retrovirus-containing cNX-Eco supernatants in nonadhesive six-well plates using the spin-fection technique (centrifugation at 910 Â g for 1.5 h in the presence of 8 Ag/mL polybrene).
Mice and irradiation. BALB/c mice were purchased from the National Cancer Institute. Green fluorescent protein transgenic (GFP-Tg) mice (19) were backcrossed into the BALB/c background for >11 generations. BM transplant recipients were lethally irradiated with two 5 Gy doses separated by 3 to 4 h using an X-ray source (RadSource RS2000 irradiator). Sublethal irradiation was at 5 Gy.
15-F 2t -isoprostane (8-iso-prostaglandin-F 2 A) analysis. 15-F 2t -isoprostane concentrations in mouse plasma were measured using a validated liquid chromatography coupled with tandem mass spectrometry method (20) . In mouse plasma, the range of reliable response of the assay was from 0.05 to 100 ng/mL. Intraday and interday accuracies were between 91.1% and 106.2%, and intraday and interday precisions were V7%. The absolute recovery of 15-F 2t -isoprostane after protein precipitation in plasma was 100.2 F 9.5%. Quantification was not affected by matrix interferences and there was no carryover.
Flow cytometry. Antibody staining and flow cytometric analyses were performed as previously described (10) . Detection of phosphorylated H2AX (gH2AX) was performed as previously described (21) using monoclonal antibody from Upstate (clone JBW301).
Statistics. Statistical analyses were performed using Prism 4 software from GraphPad. Asterisks in the figure legends represent P values of two-tailed t test, except for Kaplan-Meier survival curves (log-rank test) and Fisher's exact test for Figure 6C . See Supplementary Data for absolute P values.
Results
Irradiation permanently reduces the fitness of hematopoietic stem and progenitor cells. To study the effect of irradiation on the fitness of hematopoietic progenitors, we took advantage of the ability of competitive BM transplantation assays in mice to measure relative hematopoietic reconstitution by early progenitors. BALB/c mice were X-irradiated at 5 Gy and then allowed to recover for 3 months (Fig. 1A) . Hematopoiesis seemed fully recovered by 6 weeks after irradiation ( Supplementary Fig. S1 ). BM was harvested from irradiated mice (or from unirradiated mice as controls), mixed 9:1 with BM from GFP-Tg mice, and then transplanted into lethally irradiated recipients. Two months later, BM from these recipient mice was analyzed for GFP expression in the myeloid (GR1 + ) and B-lymphoid (B220 + ) lineages (Fig. 1A) . GFP expression was observed in the expected minor fraction of myeloid and B-lineage cells in recipients of control unirradiated BM mixed 9:1 with GFP-Tg BM. In contrast, GFP expression in these lineages approached 100% in recipients of BM from irradiated mice mixed with GFP-Tg BM. Note that a small percentage of GFP À cells are detected even in control recipients receiving 100% GFP-Tg BM (''GFP'' group), which could reflect the presence of residual host cells. Strikingly, the representation of GFP + cells in the BM was indistinguishable between recipients of 90% irradiated BM plus 10% GFP-Tg BM and recipients of 100% GFP-Tg BM, indicating that irradiation causes severe reductions in fitness when measured in competitive assays. By performing similar transplantation experiments with BM from mice irradiated 1 or 6 weeks prior, we showed that a similar loss of fitness is evident at these time points ( (Fig. 1B) . Because nonirradiated competitors would mask contributions from irradiated HSC, we used irradiated competitor BM for all experimental groups. After 22 weeks, at which point hematopoiesis should be dependent on longterm HSC activity, we measured the representation of GFP + cells in peripheral blood (Fig. 1B) . Based on the ability of different doses of BM to contribute to hematopoiesis in both the myeloid (MAC1 + ) and B-cell (B220 + ) lineages, we calculated a HSC frequency of approximately 1/13,000 for unirradiated BM and 1/133,000 for previously irradiated BM (note that prior irradiation did not affect Figure 1 . X-irradiation results in stable reductions in HSC fitness. A, BM was isolated from BALB/c mice that had been irradiated 3 mo before with 5 Gy (or not as the control) and then mixed with BM from nonirradiated GFP-Tg animals at 9:1 ratios. The mixes (or 100% GFP-Tg BM as the control) were then transplanted into lethally irradiated mice at 10 7 cells per recipient. At 2 mo after irradiation, peripheral blood was collected, stained with PE-Cy7-anti-GR1 plus PE-anti-B220 antibodies, and analyzed for the percentages of GFP + cells in the indicated blood lineages by flow cytometry. For this and all other figures, each filled circle represents data from an individual mouse. B, BM was harvested from GFP-Tg mice that had either been irradiated 8 wk before with 5 Gy or left untreated (the test cells). The indicated numbers of viable GFP + test cells (e.g., 1E4 denotes 1 Â 10 4 ) were mixed with 10 6 viable competitor BALB/c (GFP À ) BM cells isolated from donors that were irradiated 6 wk prior with 5 Gy. The mixes were injected into lethally irradiated BALB/c recipients. At 5.5 mo after transplant, peripheral blood was stained with PE-Cy7-anti-MAC1 plus PE-anti-B220 antibodies, and the percentages of GFP + cells in the MAC1 + and B220 + lineages are indicated for the 10 recipients per group. **, P < 0.01, two-tailed t test.
HSC homing to the BM; Supplementary Fig. S5 ). Thus, irradiation results in a roughly 10-fold reduction in the numbers of functional HSC, which likely contributes to reduced competitive repopulation.
Notably, reductions in numbers of HSC in previously irradiated BM are insufficient to explain the extent of dominance of nonirradiated competitors seen in competitive transplantation experiments. Using the calculated frequency of HSC, each recipient shown in Fig. 1A (Fig. 1B) . Therefore, we conclude that irradiation not only decreases the numbers of functional HSC but also substantially decreases the fitness per HSC.
Reactive oxygen species contribute to irradiation-induced impairment of hematopoietic progenitor fitness. The majority of g-irradiation-induced DNA damage, resulting both from direct hits to DNA molecules and transiently induced reactive oxygen species (ROS), occurs within milliseconds (24) . However, even long after irradiation, persistent ROS are thought to contribute to continued DNA damage even in cells not directly exposed to radiation (the ''bystander effect''; ref. 1). We therefore assayed plasma levels of 15-F 2t -isoprostane, which is produced by the random oxidation of tissue phospholipids by oxygen radicals and serves as a reliable biomarker of oxidative stress (25) . Plasma levels of 15-F 2t -isoprostane were substantially elevated by irradiation, and the increase persisted for at least 3 weeks after irradiation ( Fig. 2A) .
We next asked whether induction of secondary ROS contributes to reduced fitness of hematopoietic progenitors by using administration of the ROS scavenger N-acetyl cysteine (NAC). As expected, providing NAC before irradiation, which should reduce irradiation-induced generation of free radicals, resulted in substantially improved maintenance of long-term hematopoietic fitness ( Supplementary Fig. S3 ), as judged by competitive BM transplantation assays. In contrast, NAC treatment started after irradiation resulted in only a partial improvement of hematopoietic fitness as assessed by competition with unirradiated progenitors, in that NAC treatment after irradiation significantly improved contributions to short-term lymphopoiesis and myelopoiesis but not long-term myelopoiesis (which is dependent on HSC activity). Notably, administration of NAC after irradiation was capable of substantially reversing irradiation-induced ROS ( Fig. 2A) .
Because unirradiated BM enjoys a dramatic competitive advantage over irradiated BM, partial effects of NAC treatment after irradiation could be masked. Therefore, to better assess the effect of NAC treatment on the fitness of hematopoietic progenitors, we performed transplantation experiments where BM from irradiated NAC-treated donors competes with BM Figure 2 . NAC treatment after irradiation improves the maintenance of hematopoietic fitness. A, mice were irradiated at 5 Gy and then transferred to cages with water F 40 Amol/L NAC. 8-Iso-prostaglandin-F 2 a (8-isoPGF2a ) levels in plasma were determined as described in Materials and Methods. *, P < 0.05; **, P < 0.01; and ***, P < 0. from irradiated donors not treated with NAC (mixed 1:1; donor BM harvested 6 weeks after irradiation). As controls, similar transplants were performed with BM from unirradiated donors with or without NAC treatment. We used two sets of transplantations, where either NAC-treated or control donors were on the GFP-Tg background. Relative contributions to the myeloid lineage (MAC1 + ) were followed over time (Fig. 2B) . NAC treatment after irradiation provided clear protection from fitness loss, as BM from NAC-treated irradiated mice outcompeted BM from untreated irradiated mice irrespective of the GFP genotype of NAC-treated donors (Fig. 2B) . Given that the effects of NAC treatment were evident in the myeloid lineage 4 months after transplant (26) , NAC treatment after irradiation seems to protect the fitness of HSC. In contrast, NAC treatment had no effect on competitive repopulation using BM from unirradiated donors.
Because ROS are expected to cause DNA damage, we monitored the effects of irradiation and NAC treatment on levels of gH2AX, a commonly used marker for DNA strand breaks (27) , in BM cells. We found that almost all nucleated BM cells exhibited high gH2AX staining within 2 hours of irradiation and about a third of cells exhibited gH2AX staining 7 days after irradiation (Fig. 3A and B) . Treatment of mice with NAC after irradiation significantly reduced the persistence of DNA damage at 7 days. Irradiation caused a clear increase in the fraction of reticulocytes with micronuclei, an established readout for chromosomal strand breaks in vivo, although in contrast to gH2AX staining the reticulocyte micronuclei assay did not reveal any alleviation of DNA breaks by NAC treatment (Supplementary Fig. S6A ). Induction of massive cell death in the BM and initial disruption of hematopoiesis were insensitive to NAC treatment, although peripheral leukocyte counts trend a little higher in the NAC group on day 7 ( Fig. 3C ; Supplementary Fig. S6B ).
Thus, inhibiting the prolonged induction of ROS after irradiation can partially alleviate the persistent fitness loss of hematopoietic progenitors, likely by partially limiting persistent DNA damage. Notably, by 6 weeks after irradiation, BM progenitors exhibit cell cycle profiles indistinguishable from BM from unirradiated mice. Still, a small but consistent increase in the fraction of cells with sub-G 1 DNA content (indicative of apoptosis) and modestly increased p53 protein levels were evident irrespective of NAC treatment ( Supplementary Fig. S6C and D) . Nonetheless, the exact mechanisms responsible for irradiation-induced loss of hematopoietic progenitor cell fitness are not clear.
Irradiation leads to long-lasting alterations of the adaptive landscape, changing the selective effects of oncogenic mutations. We previously showed that conditions that impair DNA replication in hematopoietic progenitor cells dramatically increase the selective advantage conferred by Bcr-Abl, leading to enhanced leukemogenesis (10) . Because irradiation causes a dramatic and persistent impairment of hematopoietic fitness, we decided to test if prior irradiation can affect the ability of different oncogenes to drive clonal expansion of hematopoietic cells and cause leukemias. BM was harvested from mice irradiated 2 months prior at 5 Gy, transduced with MiG retroviruses encoding several different oncogenes at a sufficient efficiency to induce leukemias in recipients of nonirradiated BM, and then transplanted into recipient mice. The recipients of vector-transduced BM exhibited similar contributions of GFP-expressing cells to the myeloid and B-cell lineage, independent of prior irradiation, and thus, previous irradiation does not seem to affect retroviral transduction (Fig. 4) . + cells at the indicated time points are plotted (five to six mice per group). *, P < 0.05, two-tailed t test. C, leukocyte counts from peripheral blood were determined using automated complete blood count (CBC) analysis.
At 1 month after transplantation, recipients of nonirradiated BM transduced with p185-Bcr-Abl or activated N-Ras12D displayed high percentages of GFP + cells in peripheral blood (in B cells for Bcr-Abl and in both myeloid and B cells for Ras), suggesting a strong selective advantage in BM progenitors (Fig. 4) . In striking contrast, percentages of GFP + cells were quite low in peripheral blood of recipients that were transplanted with BM from previously irradiated recipients which had been transduced with Bcr-Abl or Ras, indicating that previous irradiation blunts the selective advantage conferred by either oncogene (Fig. 4) . Note that prior irradiation did not affect the activation of downstream effectors by these oncogenes (Supplementary Fig. S7 ). Prior irradiation had no clear effect on the expansion of hematopoietic progenitor cells expressing Myc, Bcl2, or activated Akt ( Fig. 4; Supplementary  Fig. S8 ). In contrast, we observed a stronger selection for cells that express ICN, the intracellular domain of Notch1 that possesses constitutive transcriptional activity (28) , in previously irradiated BM (Fig. 4) .
Observed differences in the expansion of oncogene-expressing cells translated into difference in leukemogenesis: previous irradiation decreased or substantially delayed leukemogenesis driven by Ras or Bcr-Abl, increased leukemogenesis driven by ICN, and had no significant effect on leukemias induced by Akt and Myc (Fig. 5) . Thus, prior irradiation can alter the adaptive landscape, either increasing or decreasing the selective effects of particular oncogenic mutations. Of note, previous irradiation had no noticeable effect on the types of leukemias that developed from the introduction of specific oncogenes, with ICN expression promoting CD4 + CD8 + T-cell leukemias, Ras or Myc expression promoting mixed B-lineage/myeloid leukemias, and Akt inducing mostly Lin À leukemias, in each case irrespective of irradiation (data not shown).
The results presented in Figs. 4 and 5 do not exclude the possibility that irradiation induces specific oncogenic alterations that are capable of cooperating with ICN, but not with other tested oncogenes, in promoting expansion and leukemogenesis. Should this be the case, the effects of irradiation on ICN-driven leukemogenesis would be expected to be cell autonomous. We therefore examined the effect of nonirradiated competitors on the ability of ICN to drive clonal expansion and leukemogenesis from previously irradiated hematopoietic progenitors. BM was isolated from mice that were irradiated 6 weeks before (IR) or left untreated (C) and then transduced with MiG-ICN (IR/ICN or C/ICN). Transduced progenitors were then transplanted into lethally + and B220 + cells as well as within total nucleated blood cells. *, P < 0.05; **, P < 0.01; and ***, P < 0.001, two-tailed t test. irradiated recipients, along with an excess of competitor BM cells. Cotransplantation of unirradiated progenitors (C-comp) with the ICN-transduced irradiated progenitors eliminated the increased competitive expansion observed in the irradiated background (Fig. 6A) , leading to substantially reduced leukemogenesis (Fig. 6B) . Thus, the acceleration of ICN-driven expansion and leukemogenesis by previous irradiation is in part non-cell autonomous, as restoring the fitness of hematopoiesis by transplantation of nonirradiated progenitors blocks ICN-driven leukemogenesis. Finally, if the observed expansion of ICN-expressing cells is due to random cooperating mutations, it would be expected to be monoclonal. However, analyses of T-cell receptor expression in expanding ICN + T cells in the irradiated background at 4 weeks after transplant reveals that these populations are polyclonal (Supplementary Fig. S9 ).
Because Notch1 has been implicated in self-renewal of HSC (29), we decided to test whether previous irradiation affects selection for ICN expression at the HSC level. We performed similar experiments to those described in Fig. 6A , except that the mice were sacrificed 4 weeks after transplantation. We determined the representation of GFP + ICN + cells within the HSC-enriched CD150 + CD48
À Lin À BM compartment (23) . Flow cytometric analysis of BM from these recipient mice at 4 weeks after transplantation revealed dramatic expansion of ICN-expressing cells within HSC-enriched pools only in the irradiated background. Again, the inclusion of unirradiated competitors completely reversed the selective advantage provided by ICN expression ( Fig. 6C; Supplementary Fig. S10A and B) . Thus, previous irradiation promotes selection for ICN at the level of early progenitors. ICN expression in early progenitors is known to promote T-cell development in the BM (normally restricted to the thymus) and to also inhibit B-cell development (30) . Indeed, we found that ICNexpressing progenitors completely dominated CD4 + CD8
+ T-cell pools in the BM in the irradiated background (IR/ICN+IR-comp) but not when unirradiated competitors were present ( Fig. 6D ; Supplementary Figs. S10C and D and S11B) . B-lymphopoiesis was also significantly impaired in the IR/ICN+IR-comp group of mice ( Supplementary Fig. S11A ). Unlike for HSC-enriched pools, the inclusion of irradiated competitors did allow for some expansion of ICN-expressing unirradiated cells (C/ICN+IR-comp) within BM CD4 + CD8
+ pools, again highlighting the non-cell autonomous contribution of irradiated hematopoiesis toward the expansion of ICN-initiated cells ( Fig. 6D; Supplementary Fig. S10C) . Notably, only a minor fraction (<1%) of control progenitors were transduced with MiG-ICN, and thus, even with the inclusion of irradiated competitors, nontransduced unirradiated progenitors eventually dominate hematopoiesis and restore competitiveness.
Discussion
Increased cancer rates that result from exposure to radiation or other carcinogens are generally attributed to the mutagenic actions of these agents via increasing frequencies of mutations in oncogenes and tumor suppressor genes (3, 4) . Surprisingly, evidence to support a role for g-radiation in the direct induction of oncogenic mutations is largely lacking (1, 12) . We and others have previously proposed an alternative explanation: DNA damaging carcinogens might induce growth-inhibitory conditions, which lead to selection for oncogenic mutations that confer at least partial resistance to the defect (6, (10) (11) (12) (13) . Of course, mutagenic and selective effects of carcinogens need not be mutually exclusive. UV light exposure of the skin represents perhaps the best example of a carcinogenic agent that has been shown to both directly result in oncogenic mutations (such as in p53) and to promote the clonal Figure 5 . Irradiation-induced altered selection for different oncogenes coincides with effects on leukemia development. Leukemia-free survival for mice described in Fig. 4 is graphed using Kaplan-Meier curves (n = 5/group). Spleen weights, CBC profiles, and tissue metastases were determined in sacrificed moribund mice. All mice that died succumbed to leukemia, as determined by the presence of GFP + blasts in multiple tissues at high percentages (>20% in BM), splenomegaly, and high peripheral blast counts. No recipients of MiG-transduced BM developed leukemias. **, P < 0.01, two-tailed t test.
expansion of progenitors with these mutations (31) (32) (33) . The studies described here tested the long-term effects of X-irradiation on the fitness of hematopoietic progenitor populations and on selection for different oncogenic mutations.
Previous studies have shown that the accumulation of DNA damage, resulting either from g-irradiation or DNA repair deficiency, leads to reductions in the repopulating ability of HSC (34) (35) (36) . Here, we show that sublethal irradiation affects HSC fitness both by the permanent loss of repopulating activity and by reducing the per-cell fitness of HSC that retain some repopulating capacity. We further show that persistent ROS induction that follows irradiation is partially responsible for this reduction of fitness. These results raise the possibility that people who are exposed to g-irradiation might benefit from treatment with antioxidants even if treatment is initiated after exposure.
The key finding of our study is that previous irradiation substantially alters the selective effect of certain oncogenic mutations, augmenting (ICN), inhibiting (Ras and Bcr-Abl), or not affecting (Akt and Myc) the ability of oncogenes to drive clonal expansion and leukemogenesis. These results argue against the prevailing paradigm whereby irradiation promotes leukemogenesis by inducing the accumulation of cooperating oncogenic events, as one would need to surmise that irradiation-induced oncogenic events cooperated with some oncogenes while inhibiting leukemia induction by others. Our results instead provide support for the importance of selection in oncogenesis: different oncogenic events should be adaptive for different contexts of reduced cellular fitness (or an otherwise altered environment). Alteration of selective pressures following irradiation is consistent with the idea that cancers arise within a fairly tight trajectory determined by the adaptive landscape specific for a particular tissue, developmental stage, and carcinogenic exposure (37) , which could underlie the association of particular oncogenic events with cancers initiated by particular carcinogenic contexts.
Activating mutations in Notch1 are very common in human T-cell acute lymphoblastic leukemias (28, 38) . Notch1 mutations that generate NH 2 terminally truncated proteins, predicted to functionally mimic the ICN oncoprotein, are found in over half of T-lymphomas induced in mice by g-irradiation (39) . Whereas the authors suggested that irradiation causes T-lymphomas by generating strand breaks at the Notch1 locus, our data indicate that previous irradiation creates a context that potently selects for activating Notch1 mutations in progenitor pools.
Our experiments indicate that this selection occurs within early multipotent progenitors because we detect substantial expansion of ICN-expressing cells in HSC-enriched pools of previously irradiated BM, and increased representation of ICN-expressing cells is evident within multiple hematopoietic lineages. Of relevance, a recent study showed that ICN expression is insufficient to confer self-renewal to T-precursors, as transfer of the initial polyclonal ICN-expressing CD4 + CD8
+ population into secondary recipient mice resulted in loss of these cells within a week (40) . In contrast, cells with properties of committed T-progenitors from monoclonal ICN-induced leukemias did efficiently transfer the disease. Thus, should an activating Notch1 mutation occur in a T-precursor, in all likelihood this clone would be lost long before other events could accumulate. But if the Notch1 mutation happens in a HSC and is selected for, a pool of ICN-expressing T-precursors could be maintained, which would then have the potential to accumulate additional events leading to leukemia development.
We hypothesize that irradiation can promote carcinogenesis by decreasing the fitness of progenitor cells, thereby increasing + populations was determined. *, P < 0.05; **, P < 0.01; and ***, P < 0.001, two-tailed t test, except as noted in panel C . selection for oncogenic mutations that can provide some adaptation in the face of this defect (6) . Although the results presented here support this hypothesis, they do not provide definitive proof. Increased selection for ICN-expressing cells could also be influenced by non-cell autonomous effects of irradiation on hematopoiesis. For example, irradiated hematopoietic cells could produce higher levels of inflammatory cytokines, and the transplanted nonirradiated BM could partially alleviate this environmental change by replacement of irradiated hematopoiesis. Irradiation-induced senescence of fibroblasts dramatically boosts cytokine production (41, 42) , which could be envisioned to promote tumorigenesis either by selective pro-proliferative effects of cytokines on initiated cells or by selectively impairing the fitness of noninitiated cells. Regardless, in the irradiated background, ICN mutations clearly confer a greater advantage relative to a normal background. Thus, ICN-expressing progenitors must have a fitness advantage relative to other irradiated progenitors, supporting the idea that irradiation increases cancer predisposition at least in part by altering the environment and thus the adaptive landscape.
In summary, our results argue that irradiation substantially changes the selective effect of different oncogenic mutations, either inhibiting or promoting oncogene-driven expansion. The ability of nonirradiated competitors to limit ICN-driven expansion from irradiated cells supports the idea that protecting or restoring the fitness of a stem cell population might limit the onset of cancer even when oncogenic mutations cannot be avoided.
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